5-Bromo-[1,2,4]triazolo[4,3-a]pyrazine, 95.0%, 250mg

1,2,3-TRIMETHOXY-4-VINYLBENZENE, 95%, 250mg

1-(2,2-Dimethoxyethyl)-4-methoxybenzene, 95.0%, 5g

Methyl 6-methyl-1H-indole-5-carboxylate, 97.0%, 1g

Preparation folder, Number of spaces required, 20, yellow, 1 piece 1 piece

mTOR Inhibitor-1>98.0%(HPLC)5mg

5-Chloro-3-iodopyrazolo[1,5-a]pyrimidine, 95.0%, 10g

tert-Butyl 2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)acetate, 95.0%, 1g

1-(Benzo[d]oxazol-2-yl)ethanone, 95.0%, 5g

1,6-Dibromonaphthalen-2-ol, 95.0%, 5g

6,8-Dibromo-3,4-dihydroquinolin-2(1H)-one, 95%, 1g

7-Chloro-1-benzofuran-2-carboxylic acid, 98+%, 10g

Methyl 3-chloro-5-(trifluoromethyl)picolinate, 95.0%, 1g